Sleep quality, not the number of hours on the clock, may be the reason a full eight hours of sleep still leaves you exhausted. That complaint turns up constantly in fatigue communities: the tracker logs eight hours, the goal is met, and the body still wakes up feeling like it never rested. The question underneath all of it is whether the eight-hour target does more harm than good, or whether the hours were never really the point.
Part 01: Sleep Quality vs Sleep Duration: Why 8 Hours Isn’t the Whole Story
Eight hours has become the default answer to the question of how much sleep adults need. In a joint consensus statement published in 2015, the American Academy of Sleep Medicine and the Sleep Research Society recommended that adults aged 18 to 60 sleep seven or more hours per night on a regular basis (Watson et al., 2015). Eight is the number most people carry in their heads instead. The recommendation is not wrong. It is incomplete.
Time in bed and time asleep are two different measurements. The first counts everything: the minutes spent waiting to fall asleep, the minutes spent awake in the middle of the night, and the minutes spent lying awake before the alarm. The second counts only the sleep itself. A person can spend eight hours in bed and sleep considerably less than that.
The ratio between the two is called sleep efficiency, and clinicians use it as a working measure of sleep quality. When efficiency drops, daytime function tends to drop with it, even when the total time in bed looks adequate on paper. Sleep quality, in other words, is what the eight-hour rule quietly assumes.
Sleep Quality vs Time in Bed: The Number That Matters More
Sleep efficiency is not a research abstraction. It is the number clinicians check first when someone reports feeling unrefreshed, because it separates time spent in bed from time actually asleep. Two people can log the same eight hours and end up with very different amounts of restorative sleep.
Part 02: When Sleep Quality Itself Is the Problem
For some people, sleep quality is the problem even when the clock says enough. The sleep is fragmented, too shallow, or interrupted often enough that the brain never completes the stages doing the restorative work.
A controlled experiment published in 1997 made this point cleanly (Martin et al., 1997). Volunteers slept undisturbed on one night and had their sleep fragmented on another, with interruptions delivered roughly once per minute. Total sleep time barely moved: about 419 minutes undisturbed versus 414 minutes fragmented. The architecture did move. Slow-wave sleep, the deepest stage, fell from 24 percent to 20 percent. The volunteers were objectively sleepier the next day, and their mood at 7 a.m. scored lower.
Fragmenting events do not have to wake a person fully. Breathing irregularities, mild sleep apnea, and even noise or a warm room can produce micro-arousals that the sleeper never remembers. The night feels unbroken. The sleep stages are not. This is one reason poor sleep quality can persist for years without anyone identifying it.
Part 03: When Sleep Quality Is Fine and Something Else Is Running You Down
The other possibility is that sleep quality is doing its job and something else is draining the tank. This is where blood work enters the picture, and where a few lab values that routine visits often skip can matter more than expected.
Ferritin: The Lab Value Most Fatigue Workups Skip
Ferritin is the protein that stores iron, and it reflects iron reserves long before hemoglobin starts to fall. A double-blind, randomized, placebo-controlled trial published in the BMJ in 2003 tested whether iron supplementation helps women with unexplained fatigue who were not anemic (Verdon et al., 2003). The trial enrolled 144 women aged 18 to 55 and assigned them to 80 mg of elemental iron daily or a placebo for four weeks.
Fatigue fell by 29 percent in the iron group and 13 percent in the placebo group, a difference of 0.95 points on a 10-point scale (P = 0.004). The subgroup finding is the part that stuck with people. When the researchers split participants by ferritin level, only the women with ferritin at or below 50 micrograms per liter improved. Among the rest, iron made little difference.
The effect was modest, self-reported, and limited to one sex, so it should be read with appropriate caution. It still points somewhere useful: normal hemoglobin does not rule out low iron stores. Iron is also not a supplement to take casually. Excess iron is harmful, and supplementation without a documented deficiency carries real risk, so blood work and a clinician’s judgment come first.
Thyroid function, vitamin B12, and vitamin D round out the short list of values that show up in unexplained fatigue. None of them explains every case, and each has its own pattern of symptoms. Together they cover a large share of what a standard fatigue workup can actually find.
Part 04: The Cellular Energy Angle Behind Poor Sleep Quality
There is a third layer that sits underneath both sleep quality and lab values: how efficiently the body’s cells convert nutrients into usable energy. Fatigue that survives adequate sleep and normal blood work often ends up here, in the mitochondria.
What NADH Does for Cellular Energy
NADH is the reduced form of nicotinamide adenine dinucleotide, a coenzyme that donates electrons to the first complex of the mitochondrial electron transport chain. That step sits upstream of ATP synthesis, the energy currency cells spend on everything from muscle contraction to neurotransmitter production. NADH also serves as a cofactor in the synthesis of dopamine and norepinephrine and participates in the cellular redox balance that governs oxidative stress.
Because of that role, NADH has been studied in populations whose defining symptom is fatigue that sleep does not resolve.
The Human Evidence on NADH and Sleep Quality
The first placebo-controlled trial came in 1999 (Forsyth et al., 1999). Twenty-six patients meeting CDC criteria for chronic fatigue syndrome completed a randomized, double-blind, crossover study of 10 mg of stabilized oral NADH against placebo, four weeks per arm. Eight of the 26 participants (31 percent) responded favorably on NADH, compared with two of 26 (8 percent) on placebo. The trial was small, it was funded by the manufacturer of the product tested, and the authors described it as a pilot. No severe adverse effects were reported.
A larger and more informative trial followed in 2021 (Castro-Marrero et al., 2021). Researchers randomized 207 people with myalgic encephalomyelitis/chronic fatigue syndrome to 200 mg of coenzyme Q10 plus 20 mg of NADH daily, or to placebo, for twelve weeks. The supplemented group showed a significant reduction in perceived cognitive fatigue (P < 0.001), improvement on the 40-item Fatigue Impact Scale (P = 0.022), and better health-related quality of life (P < 0.05). Two sleep measures also moved: sleep duration improved at the four-week visit (P = 0.018) and habitual sleep efficiency improved at eight weeks (P = 0.038).
Both sleep findings were within-group changes over time rather than direct comparisons against placebo, and the trial enrolled people with a diagnosed fatigue condition rather than healthy adults. The results support a direction of research, not a general claim about sleep quality in the population at large.
Why Delivery Format Matters for NADH
The endpoints in that research deserve a second look. What changed was not a laboratory reading of NAD+ levels but how participants reported feeling and sleeping: self-rated fatigue, perceived cognitive fatigue, sleep duration, and habitual sleep efficiency (Forsyth et al., 1999; Castro-Marrero et al., 2021). That broader set of measures is part of why NADH keeps surfacing in sleep quality research rather than being filed away as one more NAD+ precursor, and it is also why the delivery format gets so much attention. A compound has to arrive in usable form before any of those measures can move at all.
If NADH is unstable outside the body, it is more so inside it. The molecule is sensitive to heat, light, moisture, oxygen, and stomach acid, which is why plain tablets and capsules can lose potency on the shelf or break down before absorption. Stabilized delivery formats were developed to address that problem.
Celfull’s Celfavor NADH uses a sustained-release microsphere designed to remain stable in the gastric environment. The company reports that the technology has been granted patents in the United States, Canada, Australia, China, Japan, and South Korea. These are manufacturer claims about a delivery format rather than clinical outcome claims, and they have not been independently verified in head-to-head human trials.
(Celfavor™ NADH microspheres)
Part 05: Nutrients That Show Up in Sleep Quality Research
Beyond iron and NADH, two other nutrients appear repeatedly in sleep quality research. Neither is a sedative. Both are involved in pathways the body already uses to regulate sleep.
Magnesium and Sleep Quality in Older Adults
A double-blind, randomized, placebo-controlled trial published in the Journal of Research in Medical Sciences in 2012 gave 46 older adults with primary insomnia either 500 mg of magnesium or placebo daily for eight weeks (Abbasi et al., 2012). Compared with placebo, the magnesium group showed longer sleep time (P = 0.002), better sleep efficiency (P = 0.03), lower scores on the Insomnia Severity Index (P = 0.006), shorter time to fall asleep (P = 0.02), higher serum melatonin (P = 0.007), and lower serum cortisol (P = 0.008). Total sleep time as a whole did not differ significantly between the groups. The sample was small and the population was older adults with a diagnosed insomnia disorder.
Magnesium is generally well tolerated at these doses. People with impaired kidney function should not supplement without medical guidance, because reduced renal clearance can allow magnesium to accumulate.
Vitamin D and Sleep Quality
A separate double-blind trial enrolled 89 adults aged 20 to 50 who had poor sleep quality without a diagnosed sleep disorder (Majid et al., 2018). Participants received 50,000 IU of vitamin D3 every two weeks for eight weeks, an average of about 3,571 IU per day, or a placebo. Sleep quality scores improved significantly in the supplemented group compared with placebo, alongside shorter time to fall asleep, longer sleep duration, and better subjective sleep quality. The trial was conducted at a single center, and high-dose vitamin D is not something to self-administer without blood work.
Part 06: Conclusion: Sleep Quality Has to Be Measured, Not Assumed
The eight-hour target is a reasonable starting point, and the evidence for sleeping at least seven hours is solid (Watson et al., 2015). What it is not is a complete answer. When the hours are met and the fatigue persists, the useful question shifts from how long to how well.
That question has more than one possible answer. A sleep study can identify fragmentation that never fully wakes you (Martin et al., 1997). A blood panel that includes ferritin, vitamin B12, vitamin D, and thyroid function can surface a deficit the standard workup misses (Verdon et al., 2003). For fatigue that survives both, the mitochondria and the coenzymes that feed them remain a legitimate area of ongoing research (Forsyth et al., 1999; Castro-Marrero et al., 2021).
Some explanations sit outside nutrition altogether. Psychological factors such as depression, anxiety, and chronic stress are among the most common causes of persistent fatigue, and they can be present even when someone feels fine otherwise. So is airway anatomy: a narrow airway, nasal obstruction, or a neck structure that narrows the throat during sleep can disturb breathing many times a night without the sleeper noticing. Individual variation runs through all of it. Sleep quality is not one problem with one cause, and two people with identical tracker data and lab values can be dealing with different things.
None of this replaces a clinician. It does suggest that the number on the clock was never the whole story, and that treating it as the only variable may be exactly why so many people wake up eight hours later still tired. Sleep quality, unlike sleep duration, has to be measured rather than assumed.
References
Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA, Kushida C, Malhotra RK, Martin JL, Patel SR, Quan SF, Tasali E. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. SLEEP. 2015;38(6):843-844. PMID: 26039963. https://pubmed.ncbi.nlm.nih.gov/26039963/
Verdon F, Burnand B, Fallab Stubi CL, Bonard C, Graff M, Michaud A, Bischoff T, de Vevey M, Studer JP, Herzig L, Chapuis C, Tissot J, Pécoud A, Favrat B. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326(7399):1124. PMID: 12763985. https://pubmed.ncbi.nlm.nih.gov/12763985/
Martin SE, Wraith PK, Deary IJ, Douglas NJ. The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med. 1997. PMID: 9154863. https://pubmed.ncbi.nlm.nih.gov/9154863/
Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci. 2012;17(12):1161-1169. PMID: 23853635. https://pubmed.ncbi.nlm.nih.gov/23853635/
Majid MS, Hosseini SA, Helli B, Haghighyzade MH, Abolfathi M. The effect of vitamin D supplement on the score and quality of sleep in 20-50 year-old people with sleep disorders compared with control group. Nutr Neurosci. 2018. PMID: 28475473. https://pubmed.ncbi.nlm.nih.gov/28475473/
Forsyth LM, Preuss HG, MacDowell AL, Chiazze L Jr, Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol. 1999;82(2):185-191. PMID: 10071523. https://pubmed.ncbi.nlm.nih.gov/10071523/
Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Sanmartin Sentañes R, Alegre-Martin J. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021;13(8):2658. PMID: 34444817. https://pubmed.ncbi.nlm.nih.gov/34444817/
Disclaimer These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
